Burning Rock Biotech Announces Q1 Results Date
Company Announcements

Burning Rock Biotech Announces Q1 Results Date

Burning Rock Biotech (BNR) has released an update.

Burning Rock Biotech Limited, a precision oncology company, is set to unveil its unaudited financial results for Q1 2024 on May 29, 2024, before the U.S. market opens. Post-release, management will conduct a conference call to discuss the results, with live and archived webcasts available for shareholders and interested parties. The company is known for its NGS-based cancer testing and early detection solutions.

For further insights into BNR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBurning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx
TipRanks Auto-Generated NewsdeskBurning Rock Biotech Announces Executive Changes
TheFlyBurning Rock Biotech CFO Leo Li resigns
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App